¼¼°èÀÇ ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀå ±Ô¸ð Á¶»ç : ¿ëµµº°, À¯·¡º°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° Àü¸Á(2022-2032³â)
Global Autologous Cell Therapy Market Size Study, by Application, by Source, by End-Use, and Regional Forecasts 2022-2032
»óǰÄÚµå : 1514843
¸®¼­Ä¡»ç : Bizwit Research & Consulting LLP
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 7,162,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,250 £Ü 9,043,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀåÀº 2023³â ¾à 43¾ï 2,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024-2030³âÀÇ ¿¹Ãø ±â°£ µ¿¾È 22.20% ÀÌ»óÀÇ °ß½ÇÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÚ°¡ ¼¼Æ÷ Ä¡·á´Â ȯÀÚÀÇ ¼¼Æ÷(ÀϹÝÀûÀ¸·Î °ñ¼ö³ª Ç÷¾×°ú °°Àº Á¶Á÷¿¡¼­ ÃßÃâÇÑ ¼¼Æ÷)¸¦ »ç¿ëÇÏ¿© ´Ù¾çÇÑ Áúº´À» Ä¡·áÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼¼Æ÷´Â ȯÀÚ¿¡°Ô¼­ äÃëÇÏ¿© ƯÁ¤ À¯ÇüÀÇ ¼¼Æ÷(¿¹: Áٱ⼼Æ÷, ¸é¿ª¼¼Æ÷ µî)¸¦ ºÐ¸®Çϱâ À§ÇØ Ã³¸®ÇÑ ÈÄ È¯ÀÚÀÇ Ã¼³»¿¡ ´Ù½Ã ÁÖÀÔÇÕ´Ï´Ù. ÀÚ°¡ ¼¼Æ÷ Ä¡·á´Â ¾Ï, ÀÚ°¡ ¸é¿ª Áúȯ, ƯÁ¤ À¯Àü¼º Áúȯ µîÀÇ Ä¡·á¿¡ »ç¿ëµÇ¸ç, ½Åü ÀÚüÀÇ Àç»ý ´É·Â°ú ¸é¿ª ´É·ÂÀ» Ä¡·áÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. ¼¼°è ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀåÀº ¸î °¡Áö ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÎÇØ °­·ÂÇÑ ¼ºÀåÀ» º¸À̰í ÀÖ½À´Ï´Ù. ³ë·É Àα¸ Áõ°¡¿Í ¾Ï, ½Å°æ ÅðÇ༺ Áúȯ°ú °°Àº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» Å©°Ô °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

°í·É Àα¸ Áõ°¡¿Í ¾Ï, ½Å°æÅðÇ༺ Áúȯ µî ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡°¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. Àα¸ÀÇ °í·ÉÈ­´Â ³ëÈ­ °ü·Ã ÁúȯÀÇ ¹ß»ý·ü Áõ°¡·Î À̾îÁ® °í±Þ Ä¡·á ¿É¼ÇÀÌ ÇÊ¿äÇÕ´Ï´Ù. µ¿½Ã¿¡ ¸¸¼º ÁúȯÀ¸·Î Áø´Ü¹ÞÀº ȯÀÚ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó Çõ½ÅÀûÀÎ Ä¡·á¹ýÀÌ ½Ã±ÞÈ÷ ÇÊ¿äÇÏ°Ô µÇ¾ú°í, ÀÚ°¡ ¼¼Æ÷ Ä¡·á´Â ÇコÄÉ¾î ºÐ¾ß¿¡¼­ Áß¿äÇÑ °³¹ß ¹× ÅõÀÚ ºÐ¾ß·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ ½ÃÀåÀº ¼¼Æ÷ ºÐ¸® ¹× Áõ½Ä¿¡ ´ëÇÑ ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇØ ÀÌ·¯ÇÑ Ä¡·á¹ýÀ» ´õ ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖ°í ºñ¿ë È¿À²ÀûÀÏ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 3¿ù FDA´Â ºê¸®½ºÅç ¸¶À̾ ½ºÄûºê(Bristol-Myers Squibb)ÀÇ Breyanzi¸¦ Àç¹ß¼º ¶Ç´Â ºÒÀÀ¼º CLL ¶Ç´Â SLL ¼ºÀΠȯÀÚ¸¦ À§ÇÑ Ä¡·áÁ¦·Î ½ÂÀÎÇß½À´Ï´Ù. ÀÌ CAR-T ¼¼Æ÷ Ä¡·áÁ¦´Â 1ȸ Á¤¸ÆÁÖ»ç·Î Åõ¿©µË´Ï´Ù. ÁÖ¿ä ±â¾÷µéÀÇ ÀÓ»ó½ÃÇè°ú ½ÃÀå È®´ë´Â ½ÃÀå ¿ªµ¿¼ºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÚ°¡ ¼¼Æ÷ Ä¡·á¿¡ ´ëÇÑ ÅõÀÚ¿Í ¿¬±¸ Áõ°¡, °³ÀÎ ¸ÂÃãÇü ÀÇ·áÀÇ Ã¤ÅÃÀº ½ÃÀå ¼ºÀå¿¡ »õ·Î¿î ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±×·¯³ª ÀÚ°¡ ¼¼Æ÷ Ä¡·áÀÇ ³ôÀº ºñ¿ë°ú ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°ÇÀº 2024-2032³âÀÇ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

¼¼°èÀÇ ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, À¯·´, Áß³²¹Ì ¹× ±âŸ Áö¿ªÀ¸·Î, 2023³â ºÏ¹Ì´Â ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¸Àç¿Í ¼±ÁøÈ­µÈ ÀÇ·á ÀÎÇÁ¶ó·Î ÀÎÇØ ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ì±¹Àº ºÏ¹Ì¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖÀ¸¸ç, FDA ½ÂÀΰú ÅõÀÚ Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È ±Þ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´Àº ±ÔÁ¦ ȯ°æ°ú ¿¬±¸ ÀÚ±Ý Áõ°¡·Î ÀÎÇØ Å« ÀáÀç·ÂÀ» º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº Áúº´ ºÎ´ã Áõ°¡¿Í ÀÚ°¡ ¼¼Æ÷ Ä¡·á¿¡ ´ëÇÑ È°¹ßÇÑ ¿¬±¸ Ȱµ¿À¸·Î ÀÎÇØ °¡Àå ºü¸¥ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼¼°èÀÇ ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀå Á¤ÀÇ¿Í Á¶»çÀÇ ÀüÁ¦Á¶°Ç

Á¦3Àå ¼¼°èÀÇ ÀÚ°¡ ¼¼Æ÷ Ä¡·á ½ÃÀå ¿ªÇÐ

¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Autologous Cell Therapy Market is valued approximately at USD 4.32 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 22.20% over the forecast period 2024-2030. Autologous cell therapy involves using a patient's cells, typically derived from tissues like bone marrow or blood, to treat various medical conditions. These cells are harvested from the patient, processed to isolate specific types of cells (such as stem cells or immune cells), and then reintroduced into the patient's body. Autologous cell therapy is used in treatments for conditions such as cancer, autoimmune diseases, and certain genetic disorders, aiming to harness the body's own regenerative or immune capabilities for therapeutic benefit. The Global Autologous Cell Therapy Market is experiencing robust growth driven by several key factors. The rise in the geriatric population and the increasing prevalence of chronic diseases such as cancer and neurodegenerative disorders are significantly driving the market growth.

The rise in the geriatric population and the increasing prevalence of chronic diseases such as cancer and neurodegenerative disorders are significant contributors. The aging population leads to a higher incidence of age-related ailments, necessitating advanced treatment options. Simultaneously, the growing number of patients diagnosed with chronic conditions highlights the urgent need for innovative therapies, making autologous cell therapy a critical area of development and investment in the healthcare sector. Moreover, the market is witnessing technological advancements in cell isolation and expansion, making these therapies more accessible and cost-effective. For instance, in March 2024, the FDA approved Breyanzi by Bristol Myers Squibb for adults with CLL or SLL that is relapsed or refractory. This CAR-T cell therapy is given as a one-time infusion. The clinical trials and market expansions of key players are enhancing the market dynamics. Moreover, increasing investment and research in autologous cell therapies and adoption of personalized medicine are creating new opportunities to the market growth. However, the high cost of autologous cell therapy, Stringent Regulatory Requirements are hindering the market growth during the projected period 2024-2032.

Key regions considered for the global Autologous Cell Therapy market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America dominated the market, driven by the presence of major market players and advanced healthcare infrastructure. The U.S. held the largest share in the North American region and is expected to grow rapidly over the forecast period due to FDA approvals and increasing investments. Europe also shows significant potential, with supportive regulatory environments and substantial funding for research. The Asia-Pacific region is anticipated to witness the fastest growth due to the rising burden of diseases and strong research activities in autologous cell therapies.

Major market players included in this report are:

The detailed segments and sub-segment of the market are explained below:

By Application:

By Source:

By End-Use:

By Region:

Years considered for the study are as follows:

Key Takeaways:

Table of Contents

Chapter 1. Global Autologous Cell Therapy Market Executive Summary

Chapter 2. Global Autologous Cell Therapy Market Definition and Research Assumptions

Chapter 3. Global Autologous Cell Therapy Market Dynamics

Chapter 4. Global Autologous Cell Therapy Market Industry Analysis

Chapter 5. Global Autologous Cell Therapy Market Size & Forecasts by Application 2022-2032

Chapter 6. Global Autologous Cell Therapy Market Size & Forecasts by Source 2022-2032

Chapter 7. Global Autologous Cell Therapy Market Size & Forecasts by End-Use 2022-2032

Chapter 8. Global Autologous Cell Therapy Market Size & Forecasts by Region 2022-2032

Chapter 9. Competitive Intelligence

Chapter 10. Research Process

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â